Alkermes (ALKS) Long-Term Debt Repayments (2012 - 2024)
Alkermes (ALKS) reported Long-Term Debt Repayments of $750000.0 for Q3 2024, little changed year-over-year from $750000.0 in Q4 2023, and little changed quarter-over-quarter from $750000.0 in Q2 2024.
Alkermes (ALKS) Long-Term Debt Repayments (2012 - 2024) Analysis & Trends
Alkermes (ALKS) has 13 years of Long-Term Debt Repayments data on file, last reported at $750000.0 in Q3 2024.
- Long-Term Debt Repayments for Q3 2024 came in at $750000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2024 was $2.2 million (down 25.0% YoY), and the FY2024 annual result was $2.2 million, down 25.0% from the prior year.
- Long-Term Debt Repayments steadied at $750000.0 in Q3 2024 per ALKS's latest filing, from $750000.0 in the prior quarter.
- Over five years, Long-Term Debt Repayments peaked at $750000.0 in Q3 2021 and troughed at $710000.0 in Q2 2020.
- A 5-year average of $740764.7 and a median of $750000.0 in 2021 frame the typical range for Long-Term Debt Repayments.
- The sharpest annual moves came in 2020 and 2021: Long-Term Debt Repayments changed 0.0% in 2020, then rose 5.49% in 2021.
- A 5-year view of Long-Term Debt Repayments shows it stood at $711000.0 in 2020, then climbed by 5.49% to $750000.0 in 2021, then changed by 0.0% to $750000.0 in 2022, then changed by 0.0% to $750000.0 in 2023, then changed by 0.0% to $750000.0 in 2024.
- Business Quant data shows ALKS's Long-Term Debt Repayments at $750000.0 in Q3 2024, $750000.0 in Q2 2024, and $750000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 23.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 216,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 19.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 750,000.00 |
| Sep 30, 2024 | 750,000.00 |
| Jun 30, 2024 | 750,000.00 |
| Jun 30, 2024 | 750,000.00 |
| Mar 31, 2024 | 750,000.00 |
| Mar 31, 2024 | 750,000.00 |
| Dec 31, 2023 | 750,000.00 |
| Dec 31, 2023 | 750,000.00 |
| Sep 30, 2023 | 750,000.00 |
| Sep 30, 2023 | 750,000.00 |
| Jun 30, 2023 | 750,000.00 |
| Jun 30, 2023 | 750,000.00 |
| Mar 31, 2023 | 750,000.00 |
| Mar 31, 2023 | 750,000.00 |
| Dec 31, 2022 | 750,000.00 |
| Dec 31, 2022 | 750,000.00 |
| Sep 30, 2022 | 750,000.00 |
| Sep 30, 2022 | 750,000.00 |
| Jun 30, 2022 | 750,000.00 |
| Jun 30, 2022 | 750,000.00 |